This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Apple's Cult Factor Emerges as Drawback

CUPERTINO, Calif. ( TheStreet) -- I know I'm going to be yelled at for saying this, but isn't it about time we stopped the deification of Steve Jobs?

When word broke on Monday that the Apple (AAPL - Get Report) chief executive was taking a medical leave of absence, one could practically hear the collective gasps. When trading opened Tuesday, the stock slid in ferocious early trading during the morning. Articles such as this one framed the collective wisdom: "Without Steve Jobs, Questions Surround Apple."

The problem is that with or without Steve Jobs, questions will always surround Apple and, for that matter, questions will always surround every public company in existence.

Recap: Apple Earnings Blog >>

The difference, and the reason for the near-hysteria and the mammoth market reaction, is that Apple isn't just any old stock, it is the quintessential cult stock. One of the reasons that Apple is a cult stock is what we're seeing today: an unhealthy obsession with its founder and CEO.

Now don't get me wrong. I share the high regard that everybody seems to have for Steve Jobs, just as I understand why the company's products seem to engender such fanatical, cult-like loyalty. He is certainly one of the truly outstanding figures of our time, and his products are said to be pretty darn good too. One fellow I know, a cynical veteran investigative reporter, waxed rhapsodic when the subject of his Apple came up a while back. He told me that once he switched to an Apple computer, it was like a religious experience. "You never look back," he told me some time ago. Sort of like the birth of one's first child, or a seminal event like Sept. 11.

At bottom, what is happening here? Nothing more than the fact that the flesh is human, and Jobs is human. He is unwell, and the state of his health has been subject to the kind of speculation that ordinarily follows a head of state, not a CEO. Although Jobs has downplayed the extent of his cancer in the past, it speaks for itself that he is taking a medical leave a year and a half after his liver transplant was deemed to be a success.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AAPL $125.38 -0.78%
FB $83.02 -0.21%
GOOG $554.65 0.47%
TSLA $191.78 0.63%
YHOO $44.94 -0.02%


DOW 17,902.11 -74.20 -0.41%
S&P 500 2,079.35 -6.89 -0.33%
NASDAQ 4,929.4580 -17.9830 -0.36%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs